Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Agios, Asklepios, Astrazeneca, Atsena, Biomarin, Biontech, Braeburn, Camurus, Catalyst, Cend, Chugai, Genentech, Immunicum, Innocare, Innovent, Junshi, Kymera, Moderna, Oric, Pfizer, Regeneron, Roche, Rockwell, Saniona, Sanofi, Syndax, Zentalis.